Variation in Medication Therapy Management Delivery: Implications for Health Care Policy

Journal of Managed Care & Specialty Pharmacy
Margie E SnyderWilliam Doucette

Abstract

Medication therapy management (MTM) program evaluations have revealed mixed outcomes, with some studies finding favorable outcomes and others finding no differences between patients who received MTM versus those who did not. One possible reason for outcomes variability is differences in delivery of MTM programs. The Chronic Care Model (CCM) provides a framework for how health care organizations can improve care for the chronically ill through 6 elements: organization of health care, delivery system design, clinical information systems, decision support, self-management, and linkages to community resources. To apply the CCM to understand variation in MTM delivery and formulate policy recommendations. This study used a mixed-methods descriptive analysis of MTM delivery. Investigators conducted visits to a purposeful sample of MTM practices to observe MTM and interview participants. The pharmacists and staff of these practices completed a modified Assessment of Chronic Illness Care (ACIC). Pairs of investigators analyzed interview transcripts to identify themes. Demographics and ACIC scores were summarized using descriptive statistics. After analysis, investigators discussed overarching themes and policy implications organized by ...Continue Reading

References

Jul 23, 2002·Health Services Research·Amy E BonomiMichael VonKorff
Nov 22, 2005·Journal of the American Pharmacists Association : JAPhA·Benjamin M Bluml
Feb 9, 2007·Health Services Research·Elizabeth H BradleyKelly J Devers
Jul 4, 2008·Journal of the American Pharmacists Association : JAPhA·UNKNOWN American Pharmacists Association, UNKNOWN National Association of Chain Drug Stores Foundation
Mar 26, 2009·The Annals of Pharmacotherapy·Erin K WelchTroy Stubbings
May 26, 2009·International Journal of Medical Informatics·Jason J SaleemBradley N Doebbeling
Mar 16, 2012·Clinical Therapeutics·Denys T Lau, JoAnn Stubbings
Oct 25, 2012·Biochemia Medica·Mary L McHugh
Nov 18, 2014·JAMA Internal Medicine·Meera ViswanathanKathleen N Lohr
Dec 28, 2016·Journal of Managed Care & Specialty Pharmacy·Alexander MiguelRichard Segal
Apr 28, 2017·Journal of Managed Care & Specialty Pharmacy·Joseph P Vande GriendWesley Nuffer
Nov 14, 2017·Journal of the American Pharmacists Association : JAPhA·Alice C ChangMargie E Snyder

❮ Previous
Next ❯

Citations

Jul 18, 2019·BMC Medical Informatics and Decision Making·Margie E SnyderAlissa L Russ
Jun 4, 2020·Pharmacy : Journal of Pharmacy, Education and Practice·Stephanie A GernantMargie E Snyder
Aug 29, 2020·Journal of Managed Care & Specialty Pharmacy·Stephanie A GernantSean M Jeffery
Apr 21, 2020·Integrated Pharmacy Research & Practice·Stefanie P FerreriMargie E Snyder
Nov 17, 2020·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Olaf RoseKaren Luetsch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved